Category: Sponsors

Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor

by Todd | Feb 13, 2018 | General, Pharma & Biotech | 0 comments TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has today closed its previously announced “bought deal” short form prospectus offering, including the full exercise of the over-allotment option (the “Offering”). A total of 772,943 units of the Company (“Units”) were sold at a price of $18.60 per Unit (the “Issue Price”) for gross proceeds of C$14,376,740 (including the full exercise of the over-allotment option). The Offering was completed by a syndicate of underwriters led by Clarus Securities Inc. as lead underwriter and sole bookrunner, and including Haywood Securities Inc. and INFOR Financial Inc. (the “Underwriters”). Each Unit was comprised of one common share of the Company (a “Unit Share”) and one common share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one common share of the Company at a price of C$22.00 for a period of 24 months following the date hereof. The Units were offered and sold in the provinces of British Columbia, Alberta and Ontario. In connection with the Offering, the Company also issued and sold on a concurrent, “bought deal” brokered private placement of 672,125 Units for re-sale to Aphria Inc. (TSX:APH) on the same terms and conditions as the Offering for gross...

Read More

Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia

SHARE THIS POST VANCOUVER, BRITISH COLUMBIA / February 12, 2018 / Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT / OTC: ATTBF) is pleased to announce the sponsorship of a research study in partnership with Mitacs to explore the development of nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil. The research and development work will be led by scientists from Abattis and the Faculty of Land and Food Systems at the University of British Columbia (“UBC”).Mitacs is a national, not-for-profit organization that has designed and delivered research and training programs in Canada for 18 years working with 60 universities, thousands of companies, and both federal and provincial governments. In addition to the R&D work on cannabinoid-rich THC-free hemp extracts, scientist from Abattis and UBC’s Faculty of Land and Food Systems will work to create delivery platforms with increased stability and bioavailability.“Abattis is very pleased to begin working with premiere scientists from UBC, and in the University’s first-class cell-culture research facility,” said Rob Abenante, President and CEO of Abattis. Mr. Abenante added: “Our partnership will focus on developing nanoparticle-based delivery platforms since nanoparticulation allow more efficient and faster absorption of active compounds such as cannabinoids and terpenes, reducing the typical losses associated with gut absorption. This new development is part of our overall strategy to provide high-end extracts to our manufacturing partners and to support the...

Read More

Surna Completes $1.8 Million Equity Offering

SHARE THIS POST • Proceeds to be used for working capital and growth initiatives BOULDER, Colo., Dec. 13, 2017 /PRNewswire/ — Surna Inc. (the “Company”) (OTCQB: SRNA), a manufacturer of a proprietary line of application-specific lighting, environmental control and air sanitation systems for state-regulated cannabis cultivation facilities as well as traditional indoor agricultural facilities, announced today that it completed a private placement offering of investment units, at a price of $0.12 per unit, with certain accredited investors. The Company issued a total of 14,734,000 units for aggregate proceeds of $1,768,080. No placement agent or broker commissions or fees were paid in connection with the offering. Each unit consisted of one share of common stock and one three-year warrant for the purchase of one share of common stock at an exercise price of $0.20 per share.“Surna has recently expanded both its sales and project management teams with key hires, with the objective of ramping organic growth over the next 24 months, and this private placement will help further accelerate that growth plan,” stated Chris Bechtel, the Company’s Chief Executive Officer. “We are also gratified that a number of our existing stockholders expressed continued confidence in the plan by increasing their investments in the company, and we believe it is also noteworthy that Surna’s own management team subscribed for 18% of the units in this offering,” added Mr. Bechtel. About Surna...

Read More

Nutritional High Announces Approval of Calyx Acquisition by Shareholders and Entry into Definitive Agreements

SHARE THIS POST February 12, 2018 – Toronto, Ontario – Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that the shareholders of Calyx Brands Inc. (“Calyx”) have approved an acquisition of 100% of Calyx’s assets (“Acquisition”) by Nutritional High. To this end, the Company and Calyx have entered into asset purchase agreement (“APA”) setting the closing date of the acquisition at the end of February 2018. The terms of the acquisition remain unchanged from the previous update provided by the Company on November 7, 2017. Jim Frazier, CEO of Nutritional High, commented – “We are very excited to continue advancing the acquisition of Calyx and are excited to pursue a partnership that will help us secure a leading foothold in the California cannabis market. Legal sales of cannabis in California for adult use are just around the corner and having a strong distribution channel will be key in establishing Nutritional High and its brands as market leaders. We look forward to working with Mr. Dakota Sullivan and his team as we join forces in this exciting time.” Dakota Sullivan, CEO of Calyx, commented – “The Calyx team is very happy to be formally joining the Nutritional High fold. We’ve been working well together these past few months and Nutritional High’s support has been critical at this time of great...

Read More

Advantis Corp. Unexpectedly Set To Triple California Amster-Can Revenue by End of 2nd Quarter

SHARE THIS POST NEWPORT BEACH, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) — ADVANTIS CORPORATION (OTC PINK: ADVT) is currently working with new and existing partners to more than triple the total California Amster-Can canning production. Two existing partners just secured space in over 200,000 square feet of fully licensed multi-use cultivation, processing, and manufacturing facilities in 2 separate Southern California locations. Advantis is working on supplying Amster-Can canning equipment to all proprietors in both facilities. In another new development, Advantis is further expanding their reach in Northern California, which will necessitate several new canning machines be put into operation. Advantis CEO, Darren Cherry, unexpectedly revealed several new deals today that will necessitate the company adding several new canning machines to significantly increase production. “I expect our partners’ operations will be up and running very quickly, as they are among our most experienced and seasoned professionals we work with,” Cherry stated. “I am so excited to see these two partners expand in California. I hope our strong and burgeoning relationships allow us to continue growing together.” Last week, Cherry said the company was nearing capacity for their largest, most efficient machine at their home base in Newport Beach. Cherry related that the demand this immediate expansion will produce requires at least 2 new machines canning around the clock, with several more needed as their relationships expand in Northern California. I...

Read More

Mentor Capital Backs Pueblo West in Colorado Cannabis

by Todd | Feb 12, 2018 | General, Investments and M&A | 0 comments February 12, 2018SAN DIEGO–(BUSINESS WIRE)– Mentor Capital, Inc. (MNTR) announced that it has extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Cannabis veteran and Pueblo founder, Pat Leonard, comments, “Chet Billingsley and I first discussed working together back in 2013. Its great to see things come together with Mentor Capital and Pat Pen Products, which are available throughout Colorado and soon headed to other states.” As is its historic practice, Mentor would be pleased to make a series of cannabis focused investments with Pat Leonard and has set up Mentor Partner II, LLC as a vehicle for that purpose. The initial investment here is an approximately $400,000 lease of a system for supercritical extraction. Mentor CEO, Chet Billingsley reports, the timing and source of funds for this cannabis investment follow the January 23, 2018 check for $1,758,949, received by Mentor marking full recovery with interest of money owed to it by Bhang Corporation under a Judgment by the United States District Court for the Northern District of California, in Mentor’s favor and against Bhang Corporation. From an additional $286,718 also deposited by Bhang, for a total of $2,045,667, Mentor repurchased and recovered 117,000 shares of its common stock under the Judgment. In a related matter, on January 25,...

Read More